How has been the historical performance of Meghmani Organi.?

Answer:The historical performance of Meghmani Organi shows significant fluctuations in key financial metrics over the years.

Breakdown:
Meghmani Organi's net sales peaked at 2,552.62 Cr in March 2023 but saw a decline to 2,079.75 Cr by March 2025. The total operating income followed a similar trend, reaching 2,552.62 Cr in March 2023 and dropping to 2,079.75 Cr in March 2025. The raw material costs increased from 949.48 Cr in March 2021 to 1,285.71 Cr in March 2025, contributing to total expenditure rising to 1,937.00 Cr in March 2025 from 1,354.20 Cr in March 2021. Operating profit (PBDIT) experienced a significant drop from 474.75 Cr in March 2022 to 186.62 Cr in March 2025, with the operating profit margin fluctuating from 17.26% in March 2021 to 6.86% in March 2025. The profit before tax also saw a decline, moving from 408.80 Cr in March 2022 to just 9.47 Cr in March 2025, while profit after tax turned negative, recording -10.60 Cr in March 2025 compared to 237.71 Cr in March 2023. The company's total assets increased from 1,656.85 Cr in March 2020 to 3,085.41 Cr in March 2025, while total liabilities also rose, reaching 3,085.41 Cr in March 2025. Cash flow from operating activities decreased to 66.00 Cr in March 2025 from 333.00 Cr in March 2021, indicating challenges in generating cash from core operations. Overall, Meghmani Organi's financial performance reflects a volatile trajectory with notable declines in profitability and cash flow in recent years.